Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2021-02-03 Director's Dealing
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
110年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, general managers, and their family members. It shows changes in shareholdings, types of shares held, and other related insider shareholding information. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider shareholding disclosures, which corresponds to notifications of personal share transactions by company directors and executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is substantial and contains actual data, not just an announcement or certification.
2021-02-03 Chinese
110年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and executives, showing their current holdings, pledged shares, and related party holdings. It is focused on insider share ownership and changes, not on financial results, management changes, or meeting materials. There is no indication of a report or announcement of voting results, dividends, or capital changes. The content matches the description of a Director's Dealing report, which involves reporting personal share transactions or holdings by company directors and executives. The document length is 3340 characters, which is consistent with a detailed insider shareholding disclosure rather than a brief announcement or a full financial report. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2021-02-03 Chinese
109年12月營業收入
Regulatory Filings Classification · 90% confidence The document is a summarized revenue report for a company named 杏輝 for the period 民國109年12月 (December 2020). It contains monthly and cumulative net operating revenue figures, percentage changes compared to the previous year, and notes on accounting standards (IFRS) and reporting requirements. The document is short (774 characters) and primarily provides financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is more of a regulatory or compliance disclosure of revenue figures. Given the short length and nature, it is not a full financial report but a regulatory filing or announcement of summarized financial data. Therefore, the best fit is Regulatory Filings (RNS).
2021-01-11 Chinese
109年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 杏輝, providing information on fund loans and endorsement guarantees for a specific month (December 2020). It contains tabulated data on loan balances and guarantee amounts but does not include comprehensive financial statements or detailed analysis. The document length is very short (615 characters), and it appears to be a regulatory disclosure or compliance update rather than a full financial report. There is no indication of it being an annual or interim report, earnings release, or other detailed filings. Given the nature and brevity, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-01-11 Chinese
109年12月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, general managers, and their family members. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is substantial and contains actual data, not just an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is DIRS with high confidence.
2021-01-08 Chinese
109年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, pledged shares, and related percentages. It is a disclosure of insider shareholdings and pledges, which corresponds to reporting of personal share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, or other report types. The document is not a general regulatory filing or announcement but a specific insider shareholding report. Therefore, the most appropriate classification is Director's Dealing (DIRS). The document length is 3279 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2021-01-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.